Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gilda Tachedjian Ph.D."'
Publikováno v:
Drug Target Insights, Vol 2 (2007)
The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effe
Externí odkaz:
https://doaj.org/article/6cebabad8d1045fca659363987c58ab3
Publikováno v:
Drug Target Insights; 2007, Issue 2, p159-182, 24p